This HTML5 document contains 51 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1212/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q73114348
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в жовтні 1999 scientific article published on 01 October 1999 im Oktober 1999 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu n'ochobre de 1999 article scientifique publié en 1999 wetenschappelijk artikel
p:P577
wds:Q73114348-670C7154-161D-447B-8BED-0962F2C85917
wdt:P577
1999-10-01T00:00:00Z
p:P407
wds:Q73114348-602CE936-97BC-405E-99AB-A30BF4F49227
wdt:P407
wd:Q1860
p:P2093
wds:Q73114348-E3917245-60A6-40E4-AB36-AD267ED82FDE wds:Q73114348-3C53BAF2-CA92-4AB0-8AB3-2001BED99B2D wds:Q73114348-707807A6-DEFD-4BF0-B74D-B36DF8680616 wds:Q73114348-D90D0772-AEA1-452F-A6E8-34BDD62ABB73 wds:Q73114348-B55488D8-FB33-4BB5-A509-B9A770C39CD9 wds:Q73114348-F5061D76-D465-4174-8F2D-EA0728BBD557
wdt:P2093
K R Sidell L J Roberts B C Crews J D Morrow W R Markesbery L J Marnett
rdfs:label
Elevated CSF prostaglandin E2 levels in patients with probable AD Elevated CSF prostaglandin E2 levels in patients with probable AD
skos:prefLabel
Elevated CSF prostaglandin E2 levels in patients with probable AD Elevated CSF prostaglandin E2 levels in patients with probable AD
schema:name
Elevated CSF prostaglandin E2 levels in patients with probable AD Elevated CSF prostaglandin E2 levels in patients with probable AD
p:P50
wds:Q73114348-3862141E-02DE-440E-B956-27C9B6E46FB0
wdt:P50
wd:Q67207389
p:P1476
wds:Q73114348-E40936BE-0690-475B-838B-0DE59491FDE9
wdt:P1476
Elevated CSF prostaglandin E2 levels in patients with probable AD
p:P304
wds:Q73114348-DA5652C8-8B7E-4FAF-9042-6A5C79431BCC
wdt:P304
1495-1498
p:P31
wds:Q73114348-176639C1-FB5C-4CAF-AAE0-51506751C487
wdt:P31
wd:Q13442814
p:P921
wds:Q73114348-C0D15041-D8DF-4BEF-848A-F3D9D8A32C8C
wdt:P921
wd:Q416554
p:P698
wds:Q73114348-05E2223B-2D94-453D-8CCB-A19805B68E0E
wdtn:P698
n12:10534257
wdt:P698
10534257
p:P1433
wds:Q73114348-648E6030-EAB8-4155-819A-99FBFF9DAFE9
wdt:P1433
wd:Q1161692
p:P433
wds:Q73114348-25FBE9F5-C9CC-4483-ADE3-23B0B2756D19
p:P478
wds:Q73114348-073A8D08-ABC7-4016-BA16-62929DA3B388
wdt:P433
7
wdt:P478
53
p:P356
wds:Q73114348-017791E2-48A1-4B11-B3EC-4337040C21D5
wdtn:P356
n11:WNL.53.7.1495
wdt:P356
10.1212/WNL.53.7.1495